Home GlucoTrack Stock Plunges 17.84% as Fully Implantable CGM Submitted to FDA

GlucoTrack Stock Plunges 17.84% as Fully Implantable CGM Submitted to FDA

Jun 09, 2026 21:20 CST Updated 22:19
GlucoTrack

Non-invasive Blood Glucose Monitoring Device Developer